CDC endorses ACIP recommendations for COVID-19 boosters

Oct 22, 2021 - 11:01 AM
cdc-update

Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., last night recommended a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series for certain individuals at risk for severe COVID-19, as proposed by her agency’s Advisory Committee on Immunization Practices. The risk groups are the same as those previously recommended by CDC for the Pfizer booster: people age 65 and older; residents in long-term care settings; adults with underlying medical conditions; and adults who work or live in high-risk settings. 

Walensky also recommended a single COVID-19 vaccine booster dose for adults at least two months after receiving an initial Johnson & Johnson COVID-19 vaccine dose, as proposed by ACIP.

“There are now booster recommendations for all three available COVID-19 vaccines in the United States,” CDC said. “Eligible individuals may choose which vaccine they receive as a booster dose. Some people may have a preference for the vaccine type that they originally received and others, may prefer to get a different booster. CDC’s recommendations now allow for this type of mix and match dosing for booster shots.”
 

Related News Articles

Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
CDC adopts ACIP recommendations for COVID-19, chickenpox vaccines
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…